These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26517311)

  • 1. Mesoporous Silica Nanoparticles under Sintering Conditions: A Quantitative Study.
    Silencieux F; Bouchoucha M; Mercier O; Turgeon S; Chevallier P; Kleitz F; Fortin MA
    Langmuir; 2015 Dec; 31(47):13011-21. PubMed ID: 26517311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous thin films of functionalized mesoporous silica nanoparticles.
    Kobler J; Bein T
    ACS Nano; 2008 Nov; 2(11):2324-30. PubMed ID: 19206399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile preparation of ultra-large pore mesoporous silica nanoparticles and their application to the encapsulation of large guest molecules.
    Shin HS; Hwang YK; Huh S
    ACS Appl Mater Interfaces; 2014 Feb; 6(3):1740-6. PubMed ID: 24447071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of withdrawal speed on film thickness and hexagonal pore-array dimensions of SBA-15 mesoporous silica thin film.
    Hwang J; Shoji N; Endo A; Daiguji H
    Langmuir; 2014 Dec; 30(51):15550-9. PubMed ID: 25474399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Controllability of Mesoporous Silica Nanoparticles.
    Yamamoto E; Kuroda K
    Enzymes; 2018; 44():1-10. PubMed ID: 30360809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile fabrication of hollow mesoporous silica nanospheres for superhydrophilic and visible/near-IR antireflection coatings.
    Du X; He J
    Chemistry; 2011 Jul; 17(29):8165-74. PubMed ID: 21626579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
    He Q; Zhang Z; Gao F; Li Y; Shi J
    Small; 2011 Jan; 7(2):271-80. PubMed ID: 21213393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
    Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
    ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifogging and antireflection coatings fabricated by integrating solid and mesoporous silica nanoparticles without any post-treatments.
    Xu L; He J
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3293-9. PubMed ID: 22663342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile synthesis of size controllable dendritic mesoporous silica nanoparticles.
    Yu YJ; Xing JL; Pang JL; Jiang SH; Lam KF; Yang TQ; Xue QS; Zhang K; Wu P
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):22655-65. PubMed ID: 25454255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Insight into Growth Mechanism and Kinetics of Mesoporous Silica Nanoparticles by in Situ Small Angle X-ray Scattering.
    Yi Z; Dumée LF; Garvey CJ; Feng C; She F; Rookes JE; Mudie S; Cahill DM; Kong L
    Langmuir; 2015 Aug; 31(30):8478-87. PubMed ID: 26158700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
    He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
    Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of monodisperse fluorinated silica nanoparticles and their superhydrophobic thin films.
    Brassard JD; Sarkar DK; Perron J
    ACS Appl Mater Interfaces; 2011 Sep; 3(9):3583-8. PubMed ID: 21870871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
    Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
    Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.